Global Biological Multiplex Assays Market 2026 by Company, Regions, Type and Application, Forecast to 2032

November 2026 | 124 pages | ID: G0867BCD5DC8EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Biological Multiplex Assays market size was valued at US$ 3560 million in 2025 and is forecast to a readjusted size of US$ 6060 million by 2032 with a CAGR of 7.9% during review period.

The gross profit margin of major companies in the industry was approximately 45%–65%.

Biological Multiplex Assay is an analytical testing approach that simultaneously detects or quantifies multiple biological targets within a single sample. It commonly uses bead-based arrays, microarrays, flow cytometry, immunoassays, nucleic acid technologies, and related multiplex platforms to measure proteins, genes, antibodies, cytokines, or biomarkers. The technology improves sample utilization, throughput, and analytical efficiency and is widely used in life science research, clinical diagnostics, drug development, immunology, oncology, and biomarker analysis.

The industrial chain of Biological Multiplex Assay includes upstream antibodies, antigens, probes, primers, enzymes, fluorescent labels, magnetic beads, reagents, chips, and detection instruments; midstream covers assay development, reagent formulation, kit production, software analysis, validation, quality control, and testing services; downstream applications mainly include hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology companies, research institutions, universities, and clinical research organizations.

The gross profit margin of major companies in the industry was approximately 45%–65%.

Biological Multiplex Assay is an analytical testing approach that simultaneously detects or quantifies multiple biological targets within a single sample. It commonly uses bead-based arrays, microarrays, flow cytometry, immunoassays, nucleic acid technologies, and related multiplex platforms to measure proteins, genes, antibodies, cytokines, or biomarkers. The technology improves sample utilization, throughput, and analytical efficiency and is widely used in life science research, clinical diagnostics, drug development, immunology, oncology, and biomarker analysis.

The industrial chain of Biological Multiplex Assay includes upstream antibodies, antigens, probes, primers, enzymes, fluorescent labels, magnetic beads, reagents, chips, and detection instruments; midstream covers assay development, reagent formulation, kit production, software analysis, validation, quality control, and testing services; downstream applications mainly include hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology companies, research institutions, universities, and clinical research organizations.

Report Scope

This report is a detailed and comprehensive analysis for global Biological Multiplex Assays market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

  • Global Biological Multiplex Assays market size and forecasts, in consumption value ($ Million), 2021-2032
  • Global Biological Multiplex Assays market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
  • Global Biological Multiplex Assays market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
  • Global Biological Multiplex Assays market shares of main players, in revenue ($ Million), 2021-2026

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Biological Multiplex Assays
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Biological Multiplex Assays market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DiaSorin S.p.A. / Luminex Corporation, Bio-Rad Laboratories, Inc., Meso Scale Diagnostics, LLC, Thermo Fisher Scientific Inc., Quanterix Corporation, Olink Proteomics AB, QIAGEN N.V., Standard BioTools Inc., Randox Laboratories Ltd., Revvity, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Biological Multiplex Assays market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Market segment by Type

  • Bead-based Multiplex Assays
  • Microarray-based Multiplex Assays
  • Microfluidic Multiplex Assays
Market segment by Equipment Configuration

Protein Multiplex Assays

Nucleic Acid Multiplex Assays

Cellular and Multi-analyte Assays

Market segment by Maximum Test Voltage

Low-plex(≤10 Analytes)

Medium-plex(>10–50 Analytes)

High-plex(>50 Analytes)

Market segment by Application

  • Disease Biomarker Profiling
  • Drug Discovery and Development
  • Immune Response and Pathway Analysis
  • Other
Market segment by players, this report covers

DiaSorin S.p.A. / Luminex Corporation

Bio-Rad Laboratories, Inc.

Meso Scale Diagnostics, LLC

Thermo Fisher Scientific Inc.

Quanterix Corporation

Olink Proteomics AB

QIAGEN N.V.

Standard BioTools Inc.

Randox Laboratories Ltd.

Revvity, Inc.

Fujirebio Holdings, Inc.

Sysmex Corporation

Seegene Inc.

AYOXXA Biosystems GmbH

Tellgen Corporation

Autobio Diagnostics Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd.

Shanghai Fosun Long March Medical Science Co., Ltd.

Beijing Strong Biotechnologies, Inc.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Chapter Outline

Chapter 1, to describe Biological Multiplex Assays product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Biological Multiplex Assays, with revenue, gross margin, and global market share of Biological Multiplex Assays from 2021 to 2026.

Chapter 3, the Biological Multiplex Assays competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biological Multiplex Assays market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Biological Multiplex Assays.

Chapter 13, to describe Biological Multiplex Assays research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biological Multiplex Assays by Type
  1.3.1 Overview: Global Biological Multiplex Assays Market Size by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Global Biological Multiplex Assays Consumption Value Market Share by Type in 2025
  1.3.3 Bead-based Multiplex Assays
  1.3.4 Microarray-based Multiplex Assays
  1.3.5 Microfluidic Multiplex Assays
1.4 Classification of Biological Multiplex Assays by Equipment Configuration
  1.4.1 Overview: Global Biological Multiplex Assays Market Size by Equipment Configuration: 2021 Versus 2025 Versus 2032
  1.4.2 Global Biological Multiplex Assays Consumption Value Market Share by Equipment Configuration in 2025
  1.4.3 Protein Multiplex Assays
  1.4.4 Nucleic Acid Multiplex Assays
  1.4.5 Cellular and Multi-analyte Assays
1.5 Classification of Biological Multiplex Assays by Maximum Test Voltage
  1.5.1 Overview: Global Biological Multiplex Assays Market Size by Maximum Test Voltage: 2021 Versus 2025 Versus 2032
  1.5.2 Global Biological Multiplex Assays Consumption Value Market Share by Maximum Test Voltage in 2025
  1.5.3 Low-plex(≤10 Analytes)
  1.5.4 Medium-plex(>10–50 Analytes)
  1.5.5 High-plex(>50 Analytes)
1.6 Global Biological Multiplex Assays Market by Application
  1.6.1 Overview: Global Biological Multiplex Assays Market Size by Application: 2021 Versus 2025 Versus 2032
  1.6.2 Disease Biomarker Profiling
  1.6.3 Drug Discovery and Development
  1.6.4 Immune Response and Pathway Analysis
  1.6.5 Other
1.7 Global Biological Multiplex Assays Market Size & Forecast
1.8 Global Biological Multiplex Assays Market Size and Forecast by Region
  1.8.1 Global Biological Multiplex Assays Market Size by Region: 2021 VS 2025 VS 2032
  1.8.2 Global Biological Multiplex Assays Market Size by Region, (2021-2032)
  1.8.3 North America Biological Multiplex Assays Market Size and Prospect (2021-2032)
  1.8.4 Europe Biological Multiplex Assays Market Size and Prospect (2021-2032)
  1.8.5 Asia-Pacific Biological Multiplex Assays Market Size and Prospect (2021-2032)
  1.8.6 South America Biological Multiplex Assays Market Size and Prospect (2021-2032)
  1.8.7 Middle East & Africa Biological Multiplex Assays Market Size and Prospect (2021-2032)

2 COMPANY PROFILES

2.1 DiaSorin S.p.A. / Luminex Corporation
  2.1.1 DiaSorin S.p.A. / Luminex Corporation Details
  2.1.2 DiaSorin S.p.A. / Luminex Corporation Major Business
  2.1.3 DiaSorin S.p.A. / Luminex Corporation Biological Multiplex Assays Product and Solutions
  2.1.4 DiaSorin S.p.A. / Luminex Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 DiaSorin S.p.A. / Luminex Corporation Recent Developments and Future Plans
2.2 Bio-Rad Laboratories, Inc.
  2.2.1 Bio-Rad Laboratories, Inc. Details
  2.2.2 Bio-Rad Laboratories, Inc. Major Business
  2.2.3 Bio-Rad Laboratories, Inc. Biological Multiplex Assays Product and Solutions
  2.2.4 Bio-Rad Laboratories, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.3 Meso Scale Diagnostics, LLC
  2.3.1 Meso Scale Diagnostics, LLC Details
  2.3.2 Meso Scale Diagnostics, LLC Major Business
  2.3.3 Meso Scale Diagnostics, LLC Biological Multiplex Assays Product and Solutions
  2.3.4 Meso Scale Diagnostics, LLC Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 Meso Scale Diagnostics, LLC Recent Developments and Future Plans
2.4 Thermo Fisher Scientific Inc.
  2.4.1 Thermo Fisher Scientific Inc. Details
  2.4.2 Thermo Fisher Scientific Inc. Major Business
  2.4.3 Thermo Fisher Scientific Inc. Biological Multiplex Assays Product and Solutions
  2.4.4 Thermo Fisher Scientific Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.5 Quanterix Corporation
  2.5.1 Quanterix Corporation Details
  2.5.2 Quanterix Corporation Major Business
  2.5.3 Quanterix Corporation Biological Multiplex Assays Product and Solutions
  2.5.4 Quanterix Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Quanterix Corporation Recent Developments and Future Plans
2.6 Olink Proteomics AB
  2.6.1 Olink Proteomics AB Details
  2.6.2 Olink Proteomics AB Major Business
  2.6.3 Olink Proteomics AB Biological Multiplex Assays Product and Solutions
  2.6.4 Olink Proteomics AB Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Olink Proteomics AB Recent Developments and Future Plans
2.7 QIAGEN N.V.
  2.7.1 QIAGEN N.V. Details
  2.7.2 QIAGEN N.V. Major Business
  2.7.3 QIAGEN N.V. Biological Multiplex Assays Product and Solutions
  2.7.4 QIAGEN N.V. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 QIAGEN N.V. Recent Developments and Future Plans
2.8 Standard BioTools Inc.
  2.8.1 Standard BioTools Inc. Details
  2.8.2 Standard BioTools Inc. Major Business
  2.8.3 Standard BioTools Inc. Biological Multiplex Assays Product and Solutions
  2.8.4 Standard BioTools Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 Standard BioTools Inc. Recent Developments and Future Plans
2.9 Randox Laboratories Ltd.
  2.9.1 Randox Laboratories Ltd. Details
  2.9.2 Randox Laboratories Ltd. Major Business
  2.9.3 Randox Laboratories Ltd. Biological Multiplex Assays Product and Solutions
  2.9.4 Randox Laboratories Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 Randox Laboratories Ltd. Recent Developments and Future Plans
2.10 Revvity, Inc.
  2.10.1 Revvity, Inc. Details
  2.10.2 Revvity, Inc. Major Business
  2.10.3 Revvity, Inc. Biological Multiplex Assays Product and Solutions
  2.10.4 Revvity, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 Revvity, Inc. Recent Developments and Future Plans
2.11 Fujirebio Holdings, Inc.
  2.11.1 Fujirebio Holdings, Inc. Details
  2.11.2 Fujirebio Holdings, Inc. Major Business
  2.11.3 Fujirebio Holdings, Inc. Biological Multiplex Assays Product and Solutions
  2.11.4 Fujirebio Holdings, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 Fujirebio Holdings, Inc. Recent Developments and Future Plans
2.12 Sysmex Corporation
  2.12.1 Sysmex Corporation Details
  2.12.2 Sysmex Corporation Major Business
  2.12.3 Sysmex Corporation Biological Multiplex Assays Product and Solutions
  2.12.4 Sysmex Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.12.5 Sysmex Corporation Recent Developments and Future Plans
2.13 Seegene Inc.
  2.13.1 Seegene Inc. Details
  2.13.2 Seegene Inc. Major Business
  2.13.3 Seegene Inc. Biological Multiplex Assays Product and Solutions
  2.13.4 Seegene Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.13.5 Seegene Inc. Recent Developments and Future Plans
2.14 AYOXXA Biosystems GmbH
  2.14.1 AYOXXA Biosystems GmbH Details
  2.14.2 AYOXXA Biosystems GmbH Major Business
  2.14.3 AYOXXA Biosystems GmbH Biological Multiplex Assays Product and Solutions
  2.14.4 AYOXXA Biosystems GmbH Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.14.5 AYOXXA Biosystems GmbH Recent Developments and Future Plans
2.15 Tellgen Corporation
  2.15.1 Tellgen Corporation Details
  2.15.2 Tellgen Corporation Major Business
  2.15.3 Tellgen Corporation Biological Multiplex Assays Product and Solutions
  2.15.4 Tellgen Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.15.5 Tellgen Corporation Recent Developments and Future Plans
2.16 Autobio Diagnostics Co., Ltd.
  2.16.1 Autobio Diagnostics Co., Ltd. Details
  2.16.2 Autobio Diagnostics Co., Ltd. Major Business
  2.16.3 Autobio Diagnostics Co., Ltd. Biological Multiplex Assays Product and Solutions
  2.16.4 Autobio Diagnostics Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.16.5 Autobio Diagnostics Co., Ltd. Recent Developments and Future Plans
2.17 Shenzhen YHLO Biotech Co., Ltd.
  2.17.1 Shenzhen YHLO Biotech Co., Ltd. Details
  2.17.2 Shenzhen YHLO Biotech Co., Ltd. Major Business
  2.17.3 Shenzhen YHLO Biotech Co., Ltd. Biological Multiplex Assays Product and Solutions
  2.17.4 Shenzhen YHLO Biotech Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.17.5 Shenzhen YHLO Biotech Co., Ltd. Recent Developments and Future Plans
2.18 Shanghai Fosun Long March Medical Science Co., Ltd.
  2.18.1 Shanghai Fosun Long March Medical Science Co., Ltd. Details
  2.18.2 Shanghai Fosun Long March Medical Science Co., Ltd. Major Business
  2.18.3 Shanghai Fosun Long March Medical Science Co., Ltd. Biological Multiplex Assays Product and Solutions
  2.18.4 Shanghai Fosun Long March Medical Science Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.18.5 Shanghai Fosun Long March Medical Science Co., Ltd. Recent Developments and Future Plans
2.19 Beijing Strong Biotechnologies, Inc.
  2.19.1 Beijing Strong Biotechnologies, Inc. Details
  2.19.2 Beijing Strong Biotechnologies, Inc. Major Business
  2.19.3 Beijing Strong Biotechnologies, Inc. Biological Multiplex Assays Product and Solutions
  2.19.4 Beijing Strong Biotechnologies, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
  2.19.5 Beijing Strong Biotechnologies, Inc. Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Biological Multiplex Assays Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
  3.2.1 Market Share of Biological Multiplex Assays by Company Revenue
  3.2.2 Top 3 Biological Multiplex Assays Players Market Share in 2025
  3.2.3 Top 6 Biological Multiplex Assays Players Market Share in 2025
3.3 Biological Multiplex Assays Market: Overall Company Footprint Analysis
  3.3.1 Biological Multiplex Assays Market: Region Footprint
  3.3.2 Biological Multiplex Assays Market: Company Product Type Footprint
  3.3.3 Biological Multiplex Assays Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Biological Multiplex Assays Consumption Value and Market Share by Type (2021-2026)
4.2 Global Biological Multiplex Assays Market Forecast by Type (2027-2032)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Biological Multiplex Assays Consumption Value Market Share by Application (2021-2026)
5.2 Global Biological Multiplex Assays Market Forecast by Application (2027-2032)

6 NORTH AMERICA

6.1 North America Biological Multiplex Assays Consumption Value by Type (2021-2032)
6.2 North America Biological Multiplex Assays Market Size by Application (2021-2032)
6.3 North America Biological Multiplex Assays Market Size by Country
  6.3.1 North America Biological Multiplex Assays Consumption Value by Country (2021-2032)
  6.3.2 United States Biological Multiplex Assays Market Size and Forecast (2021-2032)
  6.3.3 Canada Biological Multiplex Assays Market Size and Forecast (2021-2032)
  6.3.4 Mexico Biological Multiplex Assays Market Size and Forecast (2021-2032)

7 EUROPE

7.1 Europe Biological Multiplex Assays Consumption Value by Type (2021-2032)
7.2 Europe Biological Multiplex Assays Consumption Value by Application (2021-2032)
7.3 Europe Biological Multiplex Assays Market Size by Country
  7.3.1 Europe Biological Multiplex Assays Consumption Value by Country (2021-2032)
  7.3.2 Germany Biological Multiplex Assays Market Size and Forecast (2021-2032)
  7.3.3 France Biological Multiplex Assays Market Size and Forecast (2021-2032)
  7.3.4 United Kingdom Biological Multiplex Assays Market Size and Forecast (2021-2032)
  7.3.5 Russia Biological Multiplex Assays Market Size and Forecast (2021-2032)
  7.3.6 Italy Biological Multiplex Assays Market Size and Forecast (2021-2032)

8 ASIA-PACIFIC

8.1 Asia-Pacific Biological Multiplex Assays Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Biological Multiplex Assays Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Biological Multiplex Assays Market Size by Region
  8.3.1 Asia-Pacific Biological Multiplex Assays Consumption Value by Region (2021-2032)
  8.3.2 China Biological Multiplex Assays Market Size and Forecast (2021-2032)
  8.3.3 Japan Biological Multiplex Assays Market Size and Forecast (2021-2032)
  8.3.4 South Korea Biological Multiplex Assays Market Size and Forecast (2021-2032)
  8.3.5 India Biological Multiplex Assays Market Size and Forecast (2021-2032)
  8.3.6 Southeast Asia Biological Multiplex Assays Market Size and Forecast (2021-2032)
  8.3.7 Australia Biological Multiplex Assays Market Size and Forecast (2021-2032)

9 SOUTH AMERICA

9.1 South America Biological Multiplex Assays Consumption Value by Type (2021-2032)
9.2 South America Biological Multiplex Assays Consumption Value by Application (2021-2032)
9.3 South America Biological Multiplex Assays Market Size by Country
  9.3.1 South America Biological Multiplex Assays Consumption Value by Country (2021-2032)
  9.3.2 Brazil Biological Multiplex Assays Market Size and Forecast (2021-2032)
  9.3.3 Argentina Biological Multiplex Assays Market Size and Forecast (2021-2032)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Biological Multiplex Assays Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Biological Multiplex Assays Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Biological Multiplex Assays Market Size by Country
  10.3.1 Middle East & Africa Biological Multiplex Assays Consumption Value by Country (2021-2032)
  10.3.2 Turkey Biological Multiplex Assays Market Size and Forecast (2021-2032)
  10.3.3 Saudi Arabia Biological Multiplex Assays Market Size and Forecast (2021-2032)
  10.3.4 UAE Biological Multiplex Assays Market Size and Forecast (2021-2032)

11 MARKET DYNAMICS

11.1 Biological Multiplex Assays Market Drivers
11.2 Biological Multiplex Assays Market Restraints
11.3 Biological Multiplex Assays Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Biological Multiplex Assays Industry Chain
12.2 Biological Multiplex Assays Upstream Analysis
12.3 Biological Multiplex Assays Midstream Analysis
12.4 Biological Multiplex Assays Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES

Table 1. Global Biological Multiplex Assays Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Biological Multiplex Assays Consumption Value by Equipment Configuration, (USD Million), 2021 & 2025 & 2032
Table 3. Global Biological Multiplex Assays Consumption Value by Maximum Test Voltage, (USD Million), 2021 & 2025 & 2032
Table 4. Global Biological Multiplex Assays Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Biological Multiplex Assays Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Biological Multiplex Assays Consumption Value by Region (2027-2032) & (USD Million)
Table 7. DiaSorin S.p.A. / Luminex Corporation Company Information, Head Office, and Major Competitors
Table 8. DiaSorin S.p.A. / Luminex Corporation Major Business
Table 9. DiaSorin S.p.A. / Luminex Corporation Biological Multiplex Assays Product and Solutions
Table 10. DiaSorin S.p.A. / Luminex Corporation Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. DiaSorin S.p.A. / Luminex Corporation Recent Developments and Future Plans
Table 12. Bio-Rad Laboratories, Inc. Company Information, Head Office, and Major Competitors
Table 13. Bio-Rad Laboratories, Inc. Major Business
Table 14. Bio-Rad Laboratories, Inc. Biological Multiplex Assays Product and Solutions
Table 15. Bio-Rad Laboratories, Inc. Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Table 17. Meso Scale Diagnostics, LLC Company Information, Head Office, and Major Competitors
Table 18. Meso Scale Diagnostics, LLC Major Business
Table 19. Meso Scale Diagnostics, LLC Biological Multiplex Assays Product and Solutions
Table 20. Meso Scale Diagnostics, LLC Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 22. Thermo Fisher Scientific Inc. Major Business
Table 23. Thermo Fisher Scientific Inc. Biological Multiplex Assays Product and Solutions
Table 24. Thermo Fisher Scientific Inc. Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 26. Quanterix Corporation Company Information, Head Office, and Major Competitors
Table 27. Quanterix Corporation Major Business
Table 28. Quanterix Corporation Biological Multiplex Assays Product and Solutions
Table 29. Quanterix Corporation Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Quanterix Corporation Recent Developments and Future Plans
Table 31. Olink Proteomics AB Company Information, Head Office, and Major Competitors
Table 32. Olink Proteomics AB Major Business
Table 33. Olink Proteomics AB Biological Multiplex Assays Product and Solutions
Table 34. Olink Proteomics AB Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Olink Proteomics AB Recent Developments and Future Plans
Table 36. QIAGEN N.V. Company Information, Head Office, and Major Competitors
Table 37. QIAGEN N.V. Major Business
Table 38. QIAGEN N.V. Biological Multiplex Assays Product and Solutions
Table 39. QIAGEN N.V. Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. QIAGEN N.V. Recent Developments and Future Plans
Table 41. Standard BioTools Inc. Company Information, Head Office, and Major Competitors
Table 42. Standard BioTools Inc. Major Business
Table 43. Standard BioTools Inc. Biological Multiplex Assays Product and Solutions
Table 44. Standard BioTools Inc. Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Standard BioTools Inc. Recent Developments and Future Plans
Table 46. Randox Laboratories Ltd. Company Information, Head Office, and Major Competitors
Table 47. Randox Laboratories Ltd. Major Business
Table 48. Randox Laboratories Ltd. Biological Multiplex Assays Product and Solutions
Table 49. Randox Laboratories Ltd. Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Randox Laboratories Ltd. Recent Developments and Future Plans
Table 51. Revvity, Inc. Company Information, Head Office, and Major Competitors
Table 52. Revvity, Inc. Major Business
Table 53. Revvity, Inc. Biological Multiplex Assays Product and Solutions
Table 54. Revvity, Inc. Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Revvity, Inc. Recent Developments and Future Plans
Table 56. Fujirebio Holdings, Inc. Company Information, Head Office, and Major Competitors
Table 57. Fujirebio Holdings, Inc. Major Business
Table 58. Fujirebio Holdings, Inc. Biological Multiplex Assays Product and Solutions
Table 59. Fujirebio Holdings, Inc. Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Fujirebio Holdings, Inc. Recent Developments and Future Plans
Table 61. Sysmex Corporation Company Information, Head Office, and Major Competitors
Table 62. Sysmex Corporation Major Business
Table 63. Sysmex Corporation Biological Multiplex Assays Product and Solutions
Table 64. Sysmex Corporation Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Sysmex Corporation Recent Developments and Future Plans
Table 66. Seegene Inc. Company Information, Head Office, and Major Competitors
Table 67. Seegene Inc. Major Business
Table 68. Seegene Inc. Biological Multiplex Assays Product and Solutions
Table 69. Seegene Inc. Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Seegene Inc. Recent Developments and Future Plans
Table 71. AYOXXA Biosystems GmbH Company Information, Head Office, and Major Competitors
Table 72. AYOXXA Biosystems GmbH Major Business
Table 73. AYOXXA Biosystems GmbH Biological Multiplex Assays Product and Solutions
Table 74. AYOXXA Biosystems GmbH Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. AYOXXA Biosystems GmbH Recent Developments and Future Plans
Table 76. Tellgen Corporation Company Information, Head Office, and Major Competitors
Table 77. Tellgen Corporation Major Business
Table 78. Tellgen Corporation Biological Multiplex Assays Product and Solutions
Table 79. Tellgen Corporation Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Tellgen Corporation Recent Developments and Future Plans
Table 81. Autobio Diagnostics Co., Ltd. Company Information, Head Office, and Major Competitors
Table 82. Autobio Diagnostics Co., Ltd. Major Business
Table 83. Autobio Diagnostics Co., Ltd. Biological Multiplex Assays Product and Solutions
Table 84. Autobio Diagnostics Co., Ltd. Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Autobio Diagnostics Co., Ltd. Recent Developments and Future Plans
Table 86. Shenzhen YHLO Biotech Co., Ltd. Company Information, Head Office, and Major Competitors
Table 87. Shenzhen YHLO Biotech Co., Ltd. Major Business
Table 88. Shenzhen YHLO Biotech Co., Ltd. Biological Multiplex Assays Product and Solutions
Table 89. Shenzhen YHLO Biotech Co., Ltd. Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Shenzhen YHLO Biotech Co., Ltd. Recent Developments and Future Plans
Table 91. Shanghai Fosun Long March Medical Science Co., Ltd. Company Information, Head Office, and Major Competitors
Table 92. Shanghai Fosun Long March Medical Science Co., Ltd. Major Business
Table 93. Shanghai Fosun Long March Medical Science Co., Ltd. Biological Multiplex Assays Product and Solutions
Table 94. Shanghai Fosun Long March Medical Science Co., Ltd. Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Shanghai Fosun Long March Medical Science Co., Ltd. Recent Developments and Future Plans
Table 96. Beijing Strong Biotechnologies, Inc. Company Information, Head Office, and Major Competitors
Table 97. Beijing Strong Biotechnologies, Inc. Major Business
Table 98. Beijing Strong Biotechnologies, Inc. Biological Multiplex Assays Product and Solutions
Table 99. Beijing Strong Biotechnologies, Inc. Biological Multiplex Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Beijing Strong Biotechnologies, Inc. Recent Developments and Future Plans
Table 101. Global Biological Multiplex Assays Revenue (USD Million) by Players (2021-2026)
Table 102. Global Biological Multiplex Assays Revenue Share by Players (2021-2026)
Table 103. Breakdown of Biological Multiplex Assays by Company Type (Tier 1, Tier 2, and Tier 3)
Table 104. Market Position of Players in Biological Multiplex Assays, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 105. Head Office of Key Biological Multiplex Assays Players
Table 106. Biological Multiplex Assays Market: Company Product Type Footprint
Table 107. Biological Multiplex Assays Market: Company Product Application Footprint
Table 108. Biological Multiplex Assays New Market Entrants and Barriers to Market Entry
Table 109. Biological Multiplex Assays Mergers, Acquisition, Agreements, and Collaborations
Table 110. Global Biological Multiplex Assays Consumption Value (USD Million) by Type (2021-2026)
Table 111. Global Biological Multiplex Assays Consumption Value Share by Type (2021-2026)
Table 112. Global Biological Multiplex Assays Consumption Value Forecast by Type (2027-2032)
Table 113. Global Biological Multiplex Assays Consumption Value by Application (2021-2026)
Table 114. Global Biological Multiplex Assays Consumption Value Forecast by Application (2027-2032)
Table 115. North America Biological Multiplex Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 116. North America Biological Multiplex Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 117. North America Biological Multiplex Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 118. North America Biological Multiplex Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 119. North America Biological Multiplex Assays Consumption Value by Country (2021-2026) & (USD Million)
Table 120. North America Biological Multiplex Assays Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Europe Biological Multiplex Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 122. Europe Biological Multiplex Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 123. Europe Biological Multiplex Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 124. Europe Biological Multiplex Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 125. Europe Biological Multiplex Assays Consumption Value by Country (2021-2026) & (USD Million)
Table 126. Europe Biological Multiplex Assays Consumption Value by Country (2027-2032) & (USD Million)
Table 127. Asia-Pacific Biological Multiplex Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 128. Asia-Pacific Biological Multiplex Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 129. Asia-Pacific Biological Multiplex Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Asia-Pacific Biological Multiplex Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Asia-Pacific Biological Multiplex Assays Consumption Value by Region (2021-2026) & (USD Million)
Table 132. Asia-Pacific Biological Multiplex Assays Consumption Value by Region (2027-2032) & (USD Million)
Table 133. South America Biological Multiplex Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 134. South America Biological Multiplex Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 135. South America Biological Multiplex Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 136. South America Biological Multiplex Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 137. South America Biological Multiplex Assays Consumption Value by Country (2021-2026) & (USD Million)
Table 138. South America Biological Multiplex Assays Consumption Value by Country (2027-2032) & (USD Million)
Table 139. Middle East & Africa Biological Multiplex Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 140. Middle East & Africa Biological Multiplex Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 141. Middle East & Africa Biological Multiplex Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 142. Middle East & Africa Biological Multiplex Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 143. Middle East & Africa Biological Multiplex Assays Consumption Value by Country (2021-2026) & (USD Million)
Table 144. Middle East & Africa Biological Multiplex Assays Consumption Value by Country (2027-2032) & (USD Million)
Table 145. Global Key Players of Biological Multiplex Assays Upstream (Raw Materials)
Table 146. Global Biological Multiplex Assays Typical Customers

LIST OF FIGURES

Figure 1. Biological Multiplex Assays Picture
Figure 2. Global Biological Multiplex Assays Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Biological Multiplex Assays Consumption Value Market Share by Type in 2025
Figure 4. Bead-based Multiplex Assays
Figure 5. Microarray-based Multiplex Assays
Figure 6. Microfluidic Multiplex Assays
Figure 7. Global Biological Multiplex Assays Consumption Value by Equipment Configuration, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Biological Multiplex Assays Consumption Value Market Share by Equipment Configuration in 2025
Figure 9. Protein Multiplex Assays
Figure 10. Nucleic Acid Multiplex Assays
Figure 11. Cellular and Multi-analyte Assays
Figure 12. Global Biological Multiplex Assays Consumption Value by Maximum Test Voltage, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Biological Multiplex Assays Consumption Value Market Share by Maximum Test Voltage in 2025
Figure 14. Low-plex(≤10 Analytes)
Figure 15. Medium-plex(>10–50 Analytes)
Figure 16. High-plex(>50 Analytes)
Figure 17. Global Biological Multiplex Assays Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Biological Multiplex Assays Consumption Value Market Share by Application in 2025
Figure 19. Disease Biomarker Profiling Picture
Figure 20. Drug Discovery and Development Picture
Figure 21. Immune Response and Pathway Analysis Picture
Figure 22. Other Picture
Figure 23. Global Biological Multiplex Assays Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 24. Global Biological Multiplex Assays Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 25. Global Market Biological Multiplex Assays Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 26. Global Biological Multiplex Assays Consumption Value Market Share by Region (2021-2032)
Figure 27. Global Biological Multiplex Assays Consumption Value Market Share by Region in 2025
Figure 28. North America Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 33. Company Three Recent Developments and Future Plans
Figure 34. Global Biological Multiplex Assays Revenue Share by Players in 2025
Figure 35. Biological Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 36. Market Share of Biological Multiplex Assays by Player Revenue in 2025
Figure 37. Top 3 Biological Multiplex Assays Players Market Share in 2025
Figure 38. Top 6 Biological Multiplex Assays Players Market Share in 2025
Figure 39. Global Biological Multiplex Assays Consumption Value Share by Type (2021-2026)
Figure 40. Global Biological Multiplex Assays Market Share Forecast by Type (2027-2032)
Figure 41. Global Biological Multiplex Assays Consumption Value Share by Application (2021-2026)
Figure 42. Global Biological Multiplex Assays Market Share Forecast by Application (2027-2032)
Figure 43. North America Biological Multiplex Assays Consumption Value Market Share by Type (2021-2032)
Figure 44. North America Biological Multiplex Assays Consumption Value Market Share by Application (2021-2032)
Figure 45. North America Biological Multiplex Assays Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Biological Multiplex Assays Consumption Value Market Share by Type (2021-2032)
Figure 50. Europe Biological Multiplex Assays Consumption Value Market Share by Application (2021-2032)
Figure 51. Europe Biological Multiplex Assays Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 53. France Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Biological Multiplex Assays Consumption Value Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Biological Multiplex Assays Consumption Value Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Biological Multiplex Assays Consumption Value Market Share by Region (2021-2032)
Figure 60. China Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 63. India Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Biological Multiplex Assays Consumption Value Market Share by Type (2021-2032)
Figure 67. South America Biological Multiplex Assays Consumption Value Market Share by Application (2021-2032)
Figure 68. South America Biological Multiplex Assays Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Biological Multiplex Assays Consumption Value Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Biological Multiplex Assays Consumption Value Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Biological Multiplex Assays Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 75. Saudi Arabia Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 76. UAE Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 77. Biological Multiplex Assays Market Drivers
Figure 78. Biological Multiplex Assays Market Restraints
Figure 79. Biological Multiplex Assays Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Biological Multiplex Assays Industrial Chain
Figure 82. Methodology
Figure 83. Research Process and Data Source